.png){kind=icon}
返回
Injectable Bone Tissue Engineering Using Expanded Mesenchymal Stem Cells
.png){kind=icon}
OA
AI
DOI：10.1002/stem.1300.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Patients suffering from bone defects are often treated with autologous bone transplants, but this therapy can cause many complications. New approaches are therefore needed to improve treatment for bone defects, and stem cell therapy presents an exciting alternative approach. Although extensive evidence from basic studies using stem cells has been reported, few clinical applications using stem cells for bone tissue engineering have been developed. We investigated whether injectable tissue-engineered bone (TEB) composed of mesenchymal stem cells (MSCs) and platelet-rich plasma was able to regenerate functional bone in alveolar deficiencies. We performed these studies in animals and subsequently carried out large-scale clinical studies in patients with long-term follow-up; these showed good bone formation using minimally invasive MSC transplantation. All patients exhibited significantly improved bone volume with no side effects. Newly formed bone areas at 3 months were significantly increased over the preoperation baseline (p < .001) and reached levels equivalent to that of native bone. No significant bone resorption occurred during long-term follow-up. Injectable TEB restored masticatory function in patients. This novel clinical approach represents an effective therapeutic utilization of bone tissue engineering. STEM CELLS 2013;31:572-580
Keyword:
PLATELET-RICH PLASMA
MAXILLARY SINUS
CLINICAL-APPLICATION
STROMAL CELLS
MARROW-CELLS
TRANSPLANTATION
AUGMENTATION
GRAFT
REGENERATION
TECHNOLOGY
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.6
论文数:
5.3K
被引数:
1.5W
机构
引用论文
.png){kind=icon}
分享收藏
查看更多内容